BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 3, 2002
View Archived Issues
New studies on triple therapy for H. pylori eradication reported at WCOG 2002
Read More
Merger of Alkermes and Reliant approved by boards of directors
Read More
VEGF antagonist attenuates estrogen-mediated increase in uterine mass, endometrial area
Read More
17alpha-Methyltestosterone inhibits testosterone-induced breast cancer cell growth
Read More
Plant flavonoid displays potent and selective antipoliovirus activity
Read More
LM-1685 identified as potent, selective COX-2 inhibitor
Read More
Pharmacokinetic and preliminary toxicological data presented for NSC-707545
Read More
Chemokine receptor modulators designed at Merck
Read More
New class of TAFI inhibitors described by Pfizer particularly for promoting fibrinolysis
Read More
5-HT2C antagonists claimed for Rx of anxiety, depression
Read More
Boehringer Ingelheim scientists identify new inhibitors of Abeta production
Read More
Modulators of histamine H3 receptors patented by Gliatech research team
Read More
Mutilin esters and their use in the treatment of infections
Read More
Mechanistically different drugs to treat neuropathic pain discussed at the APS meeting
Read More
BioXell launched as new biotech company
Read More
Avicena receives orphan drug status for creatine in ALS
Read More
European Commission provides financial support for diabetes project
Read More
TA-HPV gives promising phase II results in HPV-positive AGIN
Read More
NPS highlights key developments
Read More
Xcellerated T Cells evaluated in hormone-refractory prostate cancer
Read More
Nycomed signs deal to become exclusive distributor of Angiomax in 35 countries
Read More
Alizyme gets green light for phase Ib trial of ATL-104
Read More
MAA submitted for Provigil seeking label expansion in U.K.
Read More
Vivitrex enters phase III trial in alcohol-dependent patients, study in opiate users
Read More
CpG-7909 in combination with Rituxan evaluated in non-Hodgkin's lymphoma
Read More
Shire files for European approval of Xagrid
Read More